STEPHANIE RHODEBECK: Open Payments
NPI 1295031458 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 84 payments from 7 companies in 2025. Trend: 2023 $621 · 2024 $542 · 2025 $944
Food & beverage: $861Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $334 |
| Amgen Inc. | 17 | $221 |
| Janssen Biotech, Inc. | 9 | $161 |
| E.R. Squibb & Sons, L.L.C. | 10 | $152 |
| Galderma Laboratories, L.P. | 1 | $35 |
| GENZYME CORPORATION | 2 | $31 |
| Organon LLC | 1 | $8 |
Products named: SKYRIZI, OTEZLA, TREMFYA, Sotyktu, NEMLUVIO, DUPIXENT, RINVOQ, VTAMA.
Industry payments across OH — which companies pay providers there.
